LeMaitre Vascular, Inc.
LMAT Healthcare Medical Instruments & Supplies
LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.
- Revenue
- +11.3%
- EPS
- −14.3%
- Free cash flow
- −25.8%
- Total debt
- +0.53%
Quarter to September 2026, against a year earlier
Follow LMAT
Alert me
LeMaitre Vascular, Inc. (LMAT) EV/FCF
As of 5 November 2026, LeMaitre Vascular, Inc. (LMAT) trades at a EV/FCF of 25.1×. Over the past ten years it has ranged from 18.8× (July 2016) to 76.2× (June 2023); the current reading is higher than 12% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 22.1× | (57.61%) |
| FY2024 | 52.2× | 31.30% |
| FY2023 | 39.8× | (2.05%) |
| FY2022 | 40.6× | 21.43% |
| FY2021 | 33.4× | 36.09% |
| FY2020 | 24.6× | (63.27%) |
| FY2019 | 66.9× | 167.24% |
| FY2018 | 25.0× | (25.02%) |
| FY2017 | 33.4× | 5.95% |
| FY2016 | 31.5× | 3.40% |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 25.0× | (7.41%) |
| Jun 2026 | 27.0× | (7.05%) |
| Mar 2026 | 29.0× | 30.96% |
| Dec 2025 | 22.1× | (19.07%) |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| STVN Stevanato Group S.p.A. compare | −453× |
| PLSE Pulse Biosciences, Inc compare | −17.8× |
| KMTS Kestra Medical Technologies, Ltd. compare | −12.3× |
| LMAT LeMaitre Vascular, Inc. | 25.1× |
| XRAY DENTSPLY SIRONA Inc. compare | 40.0× |
| STAA STAAR Surgical Company compare | 65.4× |
| ATRC AtriCure, Inc. compare | 125× |
| WRBY Warby Parker Inc. compare | 139× |
| AZTA Azenta, Inc. compare | 144× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on LMAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement